clinical_trial

Tofersen in SOD1 ALS (VALOR)

created 4/30/2026, 2:41:24 PM

History Diff Edit
completed phase_3 NCT02623699
Intervention
Tofersen (antisense oligonucleotide targeting SOD1)
Sponsor
Biogen
Registered
Apr 30, 2026

Voting as anonymous. Sign in to attribute your signals.

tokens

Replication

No replications yet

Discussion

Posting anonymously. Sign in for attribution.

No comments yet — be the first.